DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ulocuplumab
Ulocuplumab
Predictive QSAR Tools to Aid in Early Process Development of Monoclonal Antibodies
Systemic Immunotherapy for Urothelial Cancer: Current Trends and Future Directions
Classification Decisions Taken by the Harmonized System Committee from the 47Th to 60Th Sessions (2011
On the Horizon: Immuno-Oncology (I-O) Combinations
2017 Immuno-Oncology Medicines in Development
The Evolving Landscape of `Next-Generation' Immune
The Two Tontti Tudiul Lui Hi Ha Unit
Study on Stabilization of Human Igg4 Antibodies
Orphan Drug Dummy File
Monoclonal Antibodies for the Treatment of Multiple Myeloma: an Update
Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3
Bristol-Myers Squibb Company – Product Pipeline Review – 2014
United States Patent (10 ) Patent No.: US 10,471,211 B2 Rusch Et Al
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
NETTER, Jr., Robert, C. Et Al.; Dann, Dorf- (21) International Application
2018 Medicines in Development for Cancer
(INN) for Biological and Biotechnological Substances
Top View
ASCO 2017 Investor Event
Strategies to Obtain Diverse and Specific Human Monoclonal
WO 2017/011544 Al 19 January 2017 (19.01.2017) P O PCT
Acute Myeloid Leukemia: from Biology to Clinical Practices Through Development and Pre-Clinical Therapeutics
Ulocuplumab (BMS-936564 / MDX1338)
A61K9/51 (2006.01) — with International Search Report (Art
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
2019 Universal Registration Document Including the Annual Financial Report
Monoclonal Antibodies in the Treatment of Multiple Myeloma: Current Status and Future Perspectives
Antigen Design for Successful Isolation of Highly Challenging Therapeutic Anti-GPCR Antibodies
Public Summary of Opinion on Orphan Designation Ulocuplumab for the Treatment of Acute Myeloid Leukaemia
Novel Monoclonal Antibody-Based Therapies for Acute Myeloid Leukemia T
Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3
Esophagitis: Drugs Picture of Iron Pill Material in Biopsy TT’S Kodachrome 1St Page Folder Iron Medication Injury Medications/Drugs
Classification of "Voxtalisib" (Inn List 108) And
QSAR Model Development for Early Stage Screening of Monoclonal Antibody Therapeutics to Facilitate Rapid Developability
(INN) for Biological and Biotechnological Substances
WO 2015/038777 Al 19 March 2015 (19.03.2015) P O PCT